1. High prevalence of comorbidities and use of concomitant medication in treated people living with HIV in Germany – results of the BESIDE study. (February 2021) Authors: Funke, B; Spinner, CD; Wolf, E; Heiken, H; Christensen, S; Stellbrink, HJ; Witte, V Journal: International journal of STD & AIDS Issue: Volume 32:Number 2(2021) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High prevalence of recreational and illicit drug use in German people living with HIV with a potential for drug–drug interactions with antiretroviral therapy. (January 2021) Authors: Funke, B; Spinner, CD; Esser, S; Stellbrink, HJ; Stoehr, A; Wolf, E; Koegl, C; Bruening, J; Witte, V Journal: International journal of STD & AIDS Issue: Volume 32:Number 1(2021) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2%. (June 2019) Authors: Naumann, U; Moll, A; Schleehauf, D; Lutz, KT; Schmidt, W; Jaeger, H; Funke, B; Witte, V Journal: International journal of STD & AIDS Issue: Volume 30:Number 7(2019) Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Similar efficacy and tolerability of raltegravir-based antiretroviral therapy in HIV-infected patients, irrespective of age group, burden of comorbidities and concomitant medication: Real-life analysis of the German 'WIP' cohort. (August 2017) Authors: Naumann, U; Moll, A; Schleehauf, D; Lutz, T; Schmidt, W; Jaeger, H; Funke, B; Witte, V Journal: International journal of STD & AIDS Issue: Volume 28:Number 9(2017:Sep.) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗